If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 10.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 7.00 (70.00%)
Open: 13.50
High: 13.50
Low: 13.50
Prev. Close: 13.50
HYG Live PriceLast checked at -
Seneca Growth Capital VCT is an Investment Trust

To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

B Share Portfolio Update

21 Dec 2022 07:00

B Share Portfolio Update

B Share Portfolio Update

Seneca Growth Capital VCT Plc (the "Company")

21 December 2022

B Share Pool Investment Activity since 30 June 2022

Since the June 2022 interim results, the Company has completed seven additional investments, including one follow-on investment into Arecor Therapeutics Plc, three private company investments and three new AIM quoted investments, maintaining our goal of achieving a relatively even split between unquoted and quoted investments across a diverse spread of sectors. The investments made since 30 June 2022 are as follows:

Arecor Therapeutics Plc (“Arecor”) - £0.2m follow-on investment made in August 2022 following our initial £0.4m investment at IPO. Arecor is developing a portfolio of proprietary products in diabetes and other indications with its innovative proprietary formulation technology platform, Arestat™, and working with leading pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies.Alderley Lighthouse Labs Ltd (“ALL”) - £0.5m invested in October 2022. ALL is a full service diagnostic facility in Alderley Park, with an initial focus on blood science and molecular diagnostics with capabilities to expand into histology and oncology. Oxford BioDynamics Plc (“OBD”) - £0.7m invested in October 2022. OBD is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.Bidstack Group Plc (“Bidstack”) - £1.1m invested in October 2022. Bidstack is an advertising technology company which provides dynamic, targeted and automated native in-game advertising for the global video games industry across multiple platforms.Northcoders Group plc (“Northcoders”) - £0.3m invested in November 2022. Northcoders is a market leading provider of coding and software development training for businesses and individuals. Geomiq Limited (“Geomiq”) - £0.3m invested in December 2022. Geomiq is a supply chain platform solution that allows engineers and procurement teams to shorten product development cycles and get products to market faster by leveraging technology and a machine-learning-powered matching system to connect buyers and sellers of custom manufactured parts. Convenient Collect Limited (“HubBox”) - £0.7m invested in December 2022. HubBox provides software for retailers to easily offer local pickup options at checkout for customers who want alternatives to home delivery. This software facilitates the offer of integrated flexible delivery options, including consolidation of multiple deliveries into single location/pick up points, helping to solve the ‘last mile problem’ for delivery providers, retailers and customers.

The B share pool remains well placed to make new investments and support existing B share portfolio companies with c.£5m in cash following the investment in HubBox and with a continuing fundraise under the current Offer.

B Share Pool Exits Update

The Company continues to harvest profits where possible for investors, and has made three full and partial exits to date in 2022, taking the total number of full and partial exits since 2019 to eight. The total weighted average return for exits achieved to date is 1.8x return. However, neither the exits achieved nor the valuations of the B share portfolio since 30 September 2022, the date of the last published unaudited Net Asset Value (“NAV”) per B share, have had a material impact on the NAV.

B Share Pool Dividends Update

The Company also continues to maintain its 3 pence per annum B share dividend, with its second interim dividend of 1.5 pence per B share for the year to 31 December 2022, which was paid on 16 December 2022. The Company has now paid a total of 12 pence per B share since the launch of the B share class in 2018.

The Company looks forward to providing a further update in Q1 2023.

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this information is now considered to be in the public domain.

For further information, please contact:

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

Date   Source Headline
19th May 20099:42 amRNSIssue of Equity
15th May 20093:27 pmRNSIssue of Equity
12th May 20097:00 amRNSInterim Management Statement
6th May 20097:00 amRNSResults of AGM and Issue of Equity
30th Apr 20097:00 amRNSTotal Voting Rights
16th Apr 20097:00 amRNSAvailability of Annual Accounts and Offer Letter
9th Apr 20091:04 pmRNSIssue of Equity-Replacement
9th Apr 200912:41 pmRNSIssue of Equity
9th Apr 200912:39 pmRNSOffer to Shareholders
6th Apr 20094:32 pmRNSDirector's Dealings
2nd Apr 20097:00 amRNSAnnual Report & Accounts and Notice of AGM
19th Nov 20089:54 amRNSDirector's Dealings
14th Nov 20081:08 pmRNSInterim Management Statement
28th Aug 20087:00 amRNSInterim Results
1st Aug 20084:00 pmRNSIssue of Equity
22nd Jul 20083:11 pmRNSResult of AGM
30th May 20083:25 pmRNSIssue of Equity
15th May 20087:00 amRNSInterim Management Statement
1st May 200810:55 amRNSIssue of Equity
8th Apr 20085:18 pmRNSAnnual Information Update
3rd Apr 20083:42 pmRNSIssue of Equity
19th Mar 20085:02 pmRNSOffer to shareholders
19th Mar 20085:02 pmRNSAnnual Report and Accounts
14th Jan 20085:22 pmRNSUpdate letter to Shareholders
3rd Jul 20063:56 pmRNSCompany Secretary Change
10th May 20062:49 pmRNSPurchase of Own Securities
26th Apr 20062:50 pmRNSChange of Name
25th Apr 20065:02 pmRNSDirector's Shareholding
20th Apr 20067:01 amRNSBVCT Update
20th Apr 20067:00 amRNSResult of AGM
10th Apr 20063:23 pmRNSDirector/PDMR Shareholding
3rd Apr 20064:28 pmRNSDirector's Shareholding
29th Mar 20061:09 pmRNSAnnual Information Update
24th Mar 20064:19 pmRNSFinal Results
9th Mar 20067:00 amRNSInvestment Process & Strategy
11th Nov 20054:33 pmRNSDirectorate Change
4th Nov 20054:04 pmRNSResult of AGM
3rd Oct 200511:19 amRNSNotice of AGM
27th Sep 20057:00 amRNSInterim Results
1st Sep 20058:31 amRNSBoard Changes
16th Aug 20055:51 pmRNSVCT Status
16th Aug 20059:09 amRNSVCT Status
2nd Aug 200510:56 amRNSBoard Change
12th Jul 20055:04 pmRNSBoard Changes
29th Apr 200510:22 amRNSFinal Results
14th Feb 20054:02 pmRNSIssue of Equity
9th Feb 20052:20 pmRNSCancellation of Listing
8th Feb 200511:27 amRNSCancellation of Listing
28th Jan 20052:55 pmRNSIssue of Equity
14th Jan 20053:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.